Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role
Xinrong Wang, Alfredo Maria Bove, Giuseppe Simone, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 304

Showing 1-25 of 304 citing articles:

The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF
Seyedehdelaram Ghalehbandi, Jale Yüzügülen, Md Zahidul Islam Pranjol, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175586-175586
Open Access | Times Cited: 132
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
Xiujuan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106425-106425
Closed Access | Times Cited: 73
Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
Lei Wang, Wang‐Qing Liu, Sylvain Broussy, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 37
Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 24
Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma
Shenglong Li
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 63
Retinopathy of prematurity: A review of pathophysiology and signaling pathways
Mariza Fevereiro‐Martins, Carlos Marques‐Neves, Hercília Guimarães, et al.
Survey of Ophthalmology (2022) Vol. 68, Iss. 2, pp. 175-210
Open Access | Times Cited: 51
Recent advances in metabolism and toxicity of tyrosine kinase inhibitors
Qi Zhao, Zhanxuan E. Wu, Bin Li, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108256-108256
Closed Access | Times Cited: 38
The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors
Hamidreza Zalpoor, Fatemeh Aziziyan, Mahsa Liaghat, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 33
Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors
Syeda Mahak Zahra Bokhari, Péter Hamar
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13317-13317
Open Access | Times Cited: 29
COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions
Duraisamy Kempuraj, Kristina Aenlle, Jessica R. Cohen, et al.
The Neuroscientist (2023) Vol. 30, Iss. 4, pp. 421-439
Closed Access | Times Cited: 29
Novel metal nanomaterials to promote angiogenesis in tissue regeneration
Yuki G. Yoshida, Yan Su, Hui Xu, et al.
Engineered Regeneration (2023) Vol. 4, Iss. 3, pp. 265-276
Open Access | Times Cited: 26
Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties
Samaa Saied, Moataz A. Shaldam, Mostafa M. Elbadawi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115707-115707
Closed Access | Times Cited: 24
Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021–2023)
Jing Zeng, Qichuan Deng, Zheng Chen, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107278-107278
Closed Access | Times Cited: 14
Current advances in modulating tumor hypoxia for enhanced therapeutic efficacy
Zihan Liu, Xinping Liu, Wei Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 1-27
Open Access | Times Cited: 12
Homocysteine potentiates amyloid β$$ \upbeta $$‐induced death receptor 4‐ and 5‐mediated cerebral endothelial cell apoptosis, blood brain barrier dysfunction and angiogenic impairment
Ashley M Carey, Rebecca Parodi‐Rullán, Rafael Vázquez‐Torres, et al.
Aging Cell (2024) Vol. 23, Iss. 5
Open Access | Times Cited: 10
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 8
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer
Ana K. Herrera-Vargas, Eduardo García-Rodríguez, Monserrat Olea‐Flores, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 62, pp. 23-41
Closed Access | Times Cited: 47
The roles of TGF-β and VEGF pathways in the suppression of antitumor immunity in melanoma and other solid tumors
Melissa T. Bu, Pallavi Chandrasekhar, Lizhong Ding, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108211-108211
Open Access | Times Cited: 37
Mechanical regulation of signal transduction in angiogenesis
Jennifer Flournoy, Shahad Ashkanani, Yun Chen
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 33
Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
Yannan Zheng, Wenhui Zhang, Lin Xu, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28
Approaches to the Management of Metastatic Adenoid Cystic Carcinoma
Rex H. Lee, Katherine C. Wai, Jason W. Chan, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5698-5698
Open Access | Times Cited: 28
The vascular endothelial growth factor (VEGF) system as a key regulator of ovarian follicle angiogenesis and growth
A. Guzmán, Cyndi G. Hernández‐Coronado, Carlos G. Gutiérrez, et al.
Molecular Reproduction and Development (2023) Vol. 90, Iss. 4, pp. 201-217
Open Access | Times Cited: 20
Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies
Sagiru Hamza Abdullahi, Abu Tayab Moin, Adamu Uzairu, et al.
Intelligent Pharmacy (2023) Vol. 2, Iss. 2, pp. 232-250
Open Access | Times Cited: 18
New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations
Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 14, pp. 1233-1250
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top